| Financial Year |
March 31 2023 |
| Monetary Funds |
7,895,458,842.18 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
33,975,826.58 |
| Accounts Receivable |
5,751,179,137.71 |
| Advances to Suppliers |
130,772,360.06 |
| Other Receivables |
315,631,986.87 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
562,810.95 |
| Inventories |
4,030,276,040.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
78,455,243.49 |
| Total Current Assets |
26,044,105,606.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,573,336,338.24 |
| Investment Properties |
276,655.68 |
| Fixed Assetes |
552,073,388.26 |
| Under-construction Projects |
35,751,344.05 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
253,654,493.92 |
| R&D expenses |
73,251,991.56 |
| Goodwill |
203,770,428.49 |
| Long-Term Deferred and Prepaid Expenses |
17,356,232.98 |
| Deferred Income Tax Assets |
123,074,451.51 |
| Other Non-Current Assets |
689,005,600.01 |
| Sub-Total of Non-Current Assets |
3,928,996,555.05 |
| Total Assets |
29,973,102,161.98 |
| Short-Term Loans |
252,861,027.83 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,821,002,012.73 |
| Accounts Payable |
8,054,529,650.65 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
96,637,782.81 |
| Taxes Payable |
111,581,951.49 |
| Interest Payable |
43,728,319.08 |
| Dividend Payable |
-- |
| Other payables |
2,173,877,599.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
84,606,355.76 |
| Other Current Liabilities |
2,885,055.46 |
| Sub-Total of Current Liabilities |
12,676,621,732.09 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
32,186,033.45 |
| Other Non-Current Liabilities |
747,137,426.55 |
| Sub-Total of Non-Current Liabilities |
982,501,312.25 |
| Total Liabilities |
13,659,123,044.34 |
| Paid-In Capital(Or Share Stock) |
754,502,998.00 |
| Capital Surplus |
2,348,952,642.79 |
| Surplus Reserve |
607,455,648.44 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
10,894,282,963.23 |
| Minority Stockholder's Interest |
1,680,662,454.05 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
14,633,316,663.59 |
| Owner's Equity（Stockholder's Equity） |
16,313,979,117.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
29,973,102,161.98 |
